Olaparib as salvage treatment for advanced germ cell tumors after chemotherapy failure: Results of the open-label, single-arm, IGG-02 phase II trial.

Ugo De Giorgi,Giuseppe Schepisi,Giorgia Gurioli,Carmela Pisano,Umberto Basso,Cristian Lolli,Elisabetta Petracci,Chiara Casadei,Sabrina Chiara Cecere,Laura Attademo,Alberto Clemente,Valentina Zampiga,Valentina Gallà,Ilaria Cangini,Marilena Di Napoli,Linda Valmorri,Sandro Pignata

Olaparib as salvage treatment for advanced germ cell tumors after chemotherapy failure: Results of the open-label, single-arm, IGG-02 phase II trial.

2020

Ugo De Giorgi
Giuseppe Schepisi
Giorgia Gurioli
Carmela Pisano
Umberto Basso
Cristian Lolli
Elisabetta Petracci
Chiara Casadei
Sabrina Chiara Cecere
Laura Attademo
Alberto Clemente
Valentina Zampiga
Valentina Gallà
Ilaria Cangini
Marilena Di Napoli
Linda Valmorri
Sandro Pignata

5058Background: Therapeutic options for patients with advanced germ cell tumors (GCTs) after multiple relapses or resistant disease are limited. Olaparib is an inhibitor of poly ADP ribose polymera...

Keywords:

salvage treatment
Internal medicine
open label
Olaparib
Oncology
Medicine
Germ cell tumors
Chemotherapy
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations